Scott Balsitis

1.4k total citations
18 papers, 1.1k citations indexed

About

Scott Balsitis is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Scott Balsitis has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Scott Balsitis's work include Hepatitis B Virus Studies (6 papers), Cancer-related Molecular Pathways (5 papers) and Mosquito-borne diseases and control (4 papers). Scott Balsitis is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Cancer-related Molecular Pathways (5 papers) and Mosquito-borne diseases and control (4 papers). Scott Balsitis collaborates with scholars based in United States, Canada and France. Scott Balsitis's co-authors include P. Robert Beatty, Eva Harris, Diana Flores, Paul F. Lambert, Jennifer L. Kyle, Syd Johnson, Erin Mehlhop, Katherine L. Williams, Michael Diamond and James H. McKerrow and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Scott Balsitis

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Balsitis United States 12 530 490 324 228 189 18 1.1k
Megan Schwarz United States 14 896 1.7× 775 1.6× 330 1.0× 401 1.8× 69 0.4× 19 1.4k
Claire Hutchings United Kingdom 17 261 0.5× 192 0.4× 262 0.8× 271 1.2× 64 0.3× 28 905
Simona Zompì United States 17 471 0.9× 450 0.9× 184 0.6× 233 1.0× 202 1.1× 28 1.3k
Raphaële Germi France 15 186 0.4× 317 0.6× 394 1.2× 63 0.3× 278 1.5× 49 870
Sara Calattini France 24 369 0.7× 143 0.3× 470 1.5× 121 0.5× 217 1.1× 41 1.4k
Matthias Regner Australia 19 224 0.4× 283 0.6× 312 1.0× 251 1.1× 121 0.6× 38 1.1k
Yvon Sterkers France 25 815 1.5× 86 0.2× 823 2.5× 513 2.3× 94 0.5× 70 1.9k
César López‐Camacho United Kingdom 13 300 0.6× 253 0.5× 151 0.5× 212 0.9× 71 0.4× 31 697
G. Diego Miralles United States 16 246 0.5× 532 1.1× 297 0.9× 118 0.5× 73 0.4× 21 1.2k
Lei Wen China 15 103 0.2× 299 0.6× 178 0.5× 230 1.0× 72 0.4× 40 753

Countries citing papers authored by Scott Balsitis

Since Specialization
Citations

This map shows the geographic impact of Scott Balsitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Balsitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Balsitis more than expected).

Fields of papers citing papers by Scott Balsitis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Balsitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Balsitis. The network helps show where Scott Balsitis may publish in the future.

Co-authorship network of co-authors of Scott Balsitis

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Balsitis. A scholar is included among the top collaborators of Scott Balsitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Balsitis. Scott Balsitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pan, David Z., Cameron M. Soulette, Abhishek Aggarwal, et al.. (2024). Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B. Gut. 74(4). 628–638. 4 indexed citations
2.
Mendizábal, Nieves Vélez de, et al.. (2024). Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection. CPT Pharmacometrics & Systems Pharmacology. 14(3). 420–434.
3.
Schmidt, Sarah, Stéphane Daffis, Adrian Tomkinson, et al.. (2023). Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus–Specific CD8 T-Cell Responses and High Anti–Hepatitis B Surface Antigen Titers. The Journal of Infectious Diseases. 229(4). 1077–1087. 4 indexed citations
4.
Aggarwal, Abhishek, Pamela M. Odorizzi, Jens Brodbeck, et al.. (2022). Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells. JHEP Reports. 5(4). 100664–100664. 17 indexed citations
5.
Zheng, Jim, et al.. (2020). Characterization of Seasonal Pharmacokinetic Variability in Woodchucks. Drug Metabolism and Disposition. 48(11). 1199–1209. 1 indexed citations
6.
Balsitis, Scott, Susan Chaniewski, Steven M. LeVine, et al.. (2018). Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection. PLoS ONE. 13(2). e0190058–e0190058. 37 indexed citations
7.
Niu, Congrong, Li Li, Stéphane Daffis, et al.. (2017). Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism. Journal of Hepatology. 68(5). 922–931. 71 indexed citations
8.
Tremblay, Sonia, Nathalie Dansereau, Scott Balsitis, Michael Franti, & Louie Lamorte. (2013). Development of a high-throughput human cytomegalovirus quantitative PCR cell-based assay. Journal of Virological Methods. 195. 67–71. 3 indexed citations
9.
Balsitis, Scott, Katherine L. Williams, Diana Flores, et al.. (2010). Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification. PLoS Pathogens. 6(2). e1000790–e1000790. 339 indexed citations
10.
Balsitis, Scott, et al.. (2009). Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis. Cancer Research. 69(14). 5656–5663. 54 indexed citations
11.
Balsitis, Scott, Joséfina Coloma, Glenda Castro, et al.. (2009). Tropism of Dengue Virus in Mice and Humans Defined by Viral Nonstructural Protein 3-Specific Immunostaining. American Journal of Tropical Medicine and Hygiene. 80(3). 416–424. 196 indexed citations
12.
Franti, Michael, L. M. Smith, Anders Lilja, et al.. (2009). P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes. Retrovirology. 6(S3). 1 indexed citations
13.
Kyle, Jennifer L., Scott Balsitis, Luhua Zhang, P. Robert Beatty, & Eva Harris. (2008). Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology. 380(2). 296–303. 62 indexed citations
14.
Wise‐Draper, Trisha M., Elizabeth E. Hoskins, Scott Balsitis, et al.. (2008). DEK Proto-Oncogene Expression Interferes with the Normal Epithelial Differentiation Program. American Journal Of Pathology. 174(1). 71–81. 62 indexed citations
15.
Balsitis, Scott, Frederick A. Dick, Nicholas J. Dyson, & Paul F. Lambert. (2006). Critical Roles for Non-pRb Targets of Human Papillomavirus Type 16 E7 in Cervical Carcinogenesis. Cancer Research. 66(19). 9393–9400. 63 indexed citations
16.
Balsitis, Scott, Frederick A. Dick, Denis Lee, et al.. (2005). Examination of the pRb-Dependent and pRb-Independent Functions of E7 In Vivo. Journal of Virology. 79(17). 11392–11402. 59 indexed citations
17.
18.
Balsitis, Scott, Julien Sage, Stefan Duensing, et al.. (2003). Recapitulation of the Effects of the Human Papillomavirus Type 16 E7 Oncogene on Mouse Epithelium by Somatic Rb Deletion and Detection of pRb-Independent Effects of E7 In Vivo. Molecular and Cellular Biology. 23(24). 9094–9103. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan Schwarz Breakdown of academic impact, for papers by Claire Hutchings Breakdown of academic impact, for papers by Simona Zompì Breakdown of academic impact, for papers by Raphaële Germi Breakdown of academic impact, for papers by Sara Calattini Breakdown of academic impact, for papers by Matthias Regner Breakdown of academic impact, for papers by Yvon Sterkers Breakdown of academic impact, for papers by César López‐Camacho Breakdown of academic impact, for papers by G. Diego Miralles Breakdown of academic impact, for papers by Lei Wen
Rankless by CCL
2026